Technology | November 18, 2013

GE Offers Noiseless MRI Software for Several GE Scanners

mri systems rsna 2013 GE healthcare dv24.0 silent scan software
November 18, 2013 — GE Healthcare will introduce new software to help humanize magnetic resonance imaging (MRI) with the DV24.0 Continuum Pak Silent Scan noiseless MRI at the Radiological Society of North America 2013 Annual Meeting (RSNA 2013) in Chicago. The software enhancement helps eliminate the majority of MRI noise on the Optima MR450w, Optima MR450w with GEM, Discovery MR750 and Discovery MR750w with GEM scanners.
 
Noise is one of the major complaints from patients who undergo an MRI exam. One feature of DV24.0 is Silent Scan, a technology introduced last year that is designed to reduce MR scanner noise to near ambient (background) sound levels. With this first-to-market technology, clinicians can now scan patients in silence using T1, PD, MRA acquisitions, as well as a Propeller motion-insensitive-based implementation of T2 and Flair as part of the Silent Neuro exam package.
 
DV24.0 can increase productivity up to 30 percent compared to previous generations. These improvements are possible due to workflow enhancements based on the new eXpress PreScan and Workflow 2.0 features. The new enhancements will not only increase productivity, but also drive efficiency through reducing the number of mouse clicks for technologists.
 
DV24.0 also features enhancements to increase diagnostic confidence. By evaluating top clinical needs and trends, GE MR has improved 3-D imaging through a real-time motion correction technique called Promo that automatically compensates for head motion. Additionally, DV24.0 possesses the ability to optimize for image quality and signal to noise. Focus provides high-resolution, organ-specific diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) for a small field of view. 
 
Mavric SL, a new technique designed for imaging the joints of patients with MR conditional implants, is also featured in DV24.0. It was developed in response to a growing clinical need for assessing soft tissues in the vicinity of arthroplasty and MR conditional instrumentation.  It is estimated that by 2030, arthroplasty revisions in the United States will increase by 137 percent for hips and 601 percent for knees from 2005 levels. Images generated by MAVRIC SL are intended provide data that may be useful in helping clinicians to image tissue adjacent to the MR conditional instrumentation and take action to correct complications from joint implants.
 
 
GE will also be showcasing several of its MR systems during RSNA 2013, including Discovery MR750w 3.0T, Optima MR360 Advanced and Optima MR430s. These products are built on a platform designed to help clinicians increase imaging productivity and diagnostic confidence while addressing patient comfort and the MR experience. GE MR is excited to continue putting the patient first at this year’s RSNA through patient centricity, enhanced diagnostic confidence, and efficiency with productivity.
 
The Silent Scan MRA acquisition features Focus,and Promo are U.S. Food and Drug Administration (FDA) 510(k)-pending and are not currently available for sale.
 
For more information: www.gehealthcare.com, www.rsna.org

Related Content

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...

Photo courtesy of Philips Healthcare

Feature | Radiology Business | May 31, 2019 | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look.
MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...